Pharmaceutical & Medical Packaging News editor, Daphne Allen, takes an in-depth look at the global serialization landscape. In the piece, Daphne offers a strategic view of what manufacturers should consider when selecting a serialization approach.

The paper includes real-world examples from industry thought leaders, AstraZeneca and LifeScan, to illustrate the business benefits of implementing a configurable and flexible serialization solution.

The whitepaper, Establishing a State of Readiness: Mass Serialization as a Business Strategy, is designed to help pharmaceutical manufacturers ready their operations for authentication, track and trace or ePedigree initiatives. The paper will provide you with an overview of the following:

• Global pharmaceutical serialization snapshot
• Best practices to implement a global serialization approach
• Examples of how leading pharmaceutical manufacturers, AstraZeneca and LifeScan, leveraged a configurable and expandable solution to address serialization
• Lessons learned in mitigating risk in deploying serialization
  

	Early experimentation was really critical. It has enabled risk mitigation and helped us establish a state of readiness for whatever market requirements emerge.
	– Christoph Krähenbühl, AstraZeneca

	Serialization gives us extra visibility and granularity. Cartons have unique identifiers, and we know what units are on pallets. We can identify what customer is responsible for diversion.
	– Stacey Brown, LifeScan